Histone deacetylase 3 deletion in alveolar type 2 epithelial cells prevents bleomycin-induced pulmonary fibrosis

被引：0
|
作者：
Rui Xiong
Boxin Geng
Wenyang Jiang
Yong Hu
Zhaoyu Hu
Bo Hao
Ning Li
Qing Geng
机构：
[1] Renmin Hospital of Wuhan University,Department of Thoracic Surgery
[2] Army Medical University,undefined
[3] Wuhan Rhegen Biotechnology Co.,undefined
[4] Ltd.,undefined
来源：
Clinical Epigenetics | / 15卷
关键词：
PF; HDAC3; EMT; Acetylation; GATA3;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Histone deacetylase 3 deletion in alveolar type 2 epithelial cells prevents bleomycin-induced pulmonary fibrosis
    Xiong, Rui
    Geng, Boxin
    Jiang, Wenyang
    Hu, Yong
    Hu, Zhaoyu
    Hao, Bo
    Li, Ning
    Geng, Qing
    CLINICAL EPIGENETICS, 2023, 15 (01)
  • [2] Deletion of Pou2af1 in Type II Alveolar Epithelial Cells Augments Bleomycin-Induced Pulmonary Fibrosis
    Li, Q.
    Omote, N.
    Chen, Z.
    DeIuliis, G.
    Zhu, Z.
    Herzog, E.
    Shakya, A.
    Tantin, D.
    Herazo-Maya, J. D.
    Kaminski, N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [3] Histone deacetylase inhibitor restores surfactant protein-C expression in alveolar-epithelial type II cells and attenuates bleomycin-induced pulmonary fibrosis in vivo
    Ota, Chiharu
    Yamada, Mitsuhiro
    Fujino, Naoya
    Motohashi, Hozumi
    Tando, Yukiko
    Takei, Yusuke
    Suzuki, Takaya
    Takahashi, Toru
    Kamata, Satoshi
    Makiguchi, Tomonori
    Yamaya, Mutsuo
    Kubo, Hiroshi
    EXPERIMENTAL LUNG RESEARCH, 2015, 41 (08) : 422 - 434
  • [4] ALVEOLAR EPITHELIAL-CELL PROLIFERATION IN BLEOMYCIN-INDUCED PULMONARY FIBROSIS
    CANTOR, JO
    CERRETA, JM
    OSMAN, M
    MOTT, S
    MANDL, I
    TURINO, GM
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1982, 125 (04): : 238 - 238
  • [5] Telomerase Reverse Transcriptase Deficiency In Type Ii Alveolar Epithelial Cells Enhanced Bleomycin-Induced Pulmonary Fibrosis
    Liu, T.
    De Los Santos, F. Gonzalez
    Wu, Z.
    Zhao, Y.
    Phan, S. H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [6] Alveolar epithelial TET2 is not involved in the development of bleomycin-induced pulmonary fibrosis
    Qin, Wanhai
    Crestani, Bruno
    Spek, C. Arnold
    Scicluna, Brendon P.
    van der Poll, Tom
    Duitman, JanWillem
    FASEB JOURNAL, 2021, 35 (05):
  • [7] Abnormal mitochondrial iron metabolism damages alveolar type II epithelial cells involved in bleomycin-induced pulmonary fibrosis
    Shao, Min
    Cheng, Haipeng
    Li, Xiaohong
    Qiu, Yujia
    Zhang, Yunna
    Chang, Yanfen
    Fu, Jiafeng
    Shen, Mengxia
    Xu, Xinxin
    Feng, Dandan
    Han, Yang
    Yue, Shaojie
    Zhou, Yan
    Luo, Ziqiang
    THERANOSTICS, 2024, 14 (07): : 2687 - 2705
  • [8] ALVEOLAR MACROPHAGE ACTIVATION IN BLEOMYCIN-INDUCED PULMONARY FIBROSIS
    PHAN, SH
    KUNKEL, SL
    MCGARRY, B
    FEDERATION PROCEEDINGS, 1984, 43 (04) : 886 - 886
  • [9] Erdosteine prevents bleomycin-induced pulmonary fibrosis in rats
    Sogut, S
    Ozyurt, H
    Armutcu, F
    Kart, L
    Iraz, M
    Akyol, O
    Ozen, S
    Kaplan, S
    Temel, I
    Yildirim, Z
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 494 (2-3) : 213 - 220
  • [10] Fisetin Alleviated Bleomycin-Induced Pulmonary Fibrosis Partly by Rescuing Alveolar Epithelial Cells From Senescence
    Zhang, Li
    Tong, Xiang
    Huang, Jizhen
    Wu, Man
    Zhang, Shijie
    Wang, Dongguang
    Liu, SiTong
    Fan, Hong
    FRONTIERS IN PHARMACOLOGY, 2020, 11
12345